Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
drugs
3
×
life sciences
biotech
boston blog main
exome
medical devices
national blog main
raleigh-durham blog main
raleigh-durham top stories
accelerator
airbnb
amazon web services (aws)
artificial intelligence (a.i.)
athelas
atomwise
benchling
bioinnovation capital
biolabs
biotechnology
boston
boston top stories
cancer
chemotherapy
coinbase
coworking
cruise
culture biosciences
daraprim
data analytics
deals
detroit blog main
detroit top stories
diagnostics
doordash
dropbox
drug development
drug pricing
entrepreneurship
epipen
epipens
What
life
3
×
sciences
3
×
admits
ago
big
biotech
biotechs
cash
classes
combinator
committed
companies
deploy
driving
drug
dug
far
fund
good
hatteras
healthcare
history
improved
incubator
industry
innovation
innovations
investment
investments
kicking
latest
launches
long
medical
million
new
outcomes
partners
plans
previously
Language
unset
Current search:
xconomy.com
×
sciences
×
life
×
drugs
×
@xconomy.com
4 years ago
Five Years After Y Combinator First Admits Biotechs, They’re Dug In
@xconomy.com
4 years ago
Drug Pricing: Innovation, Investment, and the Public Good
@xconomy.com
5 years ago
Hatteras Launches New Fund With $94M for Life Science Investments
